Fighting COVID-19 – both the pandemic and the recession it provoked – is President Biden’s top priority, and he is asking Congress to pass two huge economic packages. Few dispute that more relief and stimulus is needed. There’s a growing risk, however, that the new fiscal reality facing the federal government resurrects the idea of a pharma marketing tax.
The United States aims to acquire an additional 200 million doses of Covid-19 vaccines, President Joe Biden said, enough to inoculate most Americans by summertime.
The first known U.S. case of a highly infectious coronavirus variant discovered in Britain was detected in Colorado on Dec. 29 as President-elect Joe Biden warned it could take years for most Americans to be vaccinated against Covid-19 at current distribution rates.
The U.S. Congress approved an $892 billion coronavirus aid package, throwing a lifeline to the nation’s pandemic-battered economy after months of inaction, while also keeping the federal government funded.
Republican U.S. Senate Majority Leader Mitch McConnell said an agreement was reached by congressional leaders of both parties on a roughly $900 billion Covid-19 relief bill.
U.S. coronavirus deaths soared to a daily record of 3,580 and hospitalizations rose for the 19th straight day on Dec. 16, ramping up the stakes as regulators on Dec. 17 considered whether to approve a second Covid-19 vaccine.
Daily U.S. deaths from Covid-19 surpassed 3,000 for the third time in a week as the country expanded its vaccination program and Congress progressed toward approving financial relief for pandemic-stricken America.
The United States’ daily death toll from Covid-19 surpassed 3,000 for the first time, prompting pleas for Americans to scale back Christmas plans even with vaccines on the cusp of winning regulatory approval.
President-elect Joe Biden made his selections for two key public health positions, sources said, as he prepares to take office in January while the coronavirus pandemic rages to new levels across the United States.
Join TLD Group Advisor and Senior Consultant Dr. Kent Bottles in a webinar on December 3rd that will discuss American Healthcare in 2021: What Should Providers, Patients, & Citizens Expect?
